Hims & Hers Health (XSWX:HIMS) 9-Day RSI: N/A (As of Jul. 03, 2026)


XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
81 GF Score
Price CHF29.90
GF Value CHF32.30
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-03), Hims & Hers Health's 9-Day RSI is N/A.

The industry rank for Hims & Hers Health's 9-Day RSI or its related term are showing as below:

XSWX:HIMS's 9-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 51.745
* Ranked among companies with meaningful 9-Day RSI only.

Hims & Hers Health  (XSWX:HIMS) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Hims & Hers Health 9-Day RSI Related Terms


XSWX:HIMS vs : 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hims & Hers Health 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's 9-Day RSI falls into.


XSWX:HIMS
81GF Score
Hims & Hers Health Inc XSWX:HIMS
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health  (XSWX:HIMS) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF29.90 is trading 7.4% below its estimated GF Value™ of CHF32.30.

Key valuation signals for XSWX:HIMS:

  • 9-Day RSI: N/A
  • GF Value™: CHF32.30 vs. price of CHF29.90 (7.4% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for XSWX:HIMS

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.90
Price
CHF32.30
GF Value